Press Releases

Matexcel Provides a Wide Range of Metal Oxide Products for Research Use

Bora Pharmaceuticals partners with TaiRx, Inc. to manufacture breakthrough anticancer drug

BioIVT Acquires Fidelis Research

This transaction increases BioIVT's global network for collecting high-quality, disease-state biospecimens and extends its capabilities to deliver fresh biospecimens and produce cell products for drug and diagnostic development.

Abzena strengthens R&D capabilities to support rapid antibody discovery

For further information, images, and interview opportunities, please contact Kristy Harmer at ramarketing: kristy.harmer@ramarketingpr.com | +44 (0)191 222 1242 | ramarketingpr.com | Twitter: @ramarketingpr | Facebook: /ramarketingpr | Linkedin: /ramarketing About Abzena Abzena provides the most complete set of solutions in integrated early discovery to mid-phase biotherapeutic and bioconjugation drug development and manufacturing in the biopharmaceutical industry. The company maintains resources around the world, with facilities in the US and UK. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors. For more information, please see www.abzena.com

Zebrafish Disease Models: Accelerating Human Disease Studies and Biomedical Research

Microbiosci Offers Real-time PCR Kits to Support Research Applications in Viral Detection

CRISPR/Cas9 Platform Provides Accurate Gene Knockout Mouse Models for Immunology Research and Drug Discovery

Creative Bioarray Provides Cell Patterning Customization and Detection Services for Drug Screening

DDA Platform Offers A Wide Range of in Vitro and in Vivo Assays to Cover Early Stage Drug Discovery

Creative Bioarray Designs Comprehensive Tools and Protocols to Construct Animal Disease Models

Creative Enzymes Offers Products to Support the Clinical and Research Use of Liver Function Evaluation

Creative Enzymes Announces the Launch of Kex2 Protease from Saccharomyces Cerevisiae, Recombinant

Creative Proteomics Cytokine Accelerates Your Project with Its Colony Stimulating Factor Detection Service

Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals

Creative Proteomics Has Optimized Pre-treatments and Assays for Different Types of Vitamins

Elligo’s Rebecca Kush, Ph.D., Elected Chair of Vulcan Advisory Council

Elligo Health Research® today announced Chief Scientific Officer Rebecca Kush, Ph.D., will bring her expertise in clinical research, standards, and interoperability to her role as recently elected Chair of the Vulcan Advisory Council.

WCG IRB Expands Phase I Review Services, Partners With Dr. Vince Clinical Research

WCG today announced the expansion of its Phase I review services, providing purpose-built operations for Phase I investigators.

Dr. Vince Clinical Research Opens Industry-Leading Clinical Pharmacology Unit

Dr. Vince Clinical Research (DVCR) today announced the launch of its new, world-class clinical pharmacology unit and headquarters in Overland Park, Kansas.

University of Maryland School of Pharmacy Taps Komodo Health Platform To Power Real-World Evidence Research

Studies Will Examine Social Determinants of Health, Impact of Policy on Access, and Pandemic-Driven Disruptions to Healthcare Delivery

Quinten Health closes its financing round to advance disease modeling platforms and virtual twins in real-world

QUINTEN HEALTH has announced that it has closed its financing round to advance disease modeling platforms and virtual twins in real-world.